purinergic receptor P2X 2
| GO Term | Evidence Code | PMID |
|---|---|---|
| response to hypoxia | ||
| response to ischemia | ||
| detection of hypoxic conditions in blood by carotid body chemoreceptor signaling | ||
| neuromuscular synaptic transmission | ||
| neuromuscular junction development |
| GO Term | Evidence Code | PMID |
|---|---|---|
| plasma membrane | ||
| plasma membrane | ||
| plasma membrane | ||
| apical plasma membrane | ||
| neuronal cell body |
| GO Term | Evidence Code | PMID |
|---|---|---|
| purinergic nucleotide receptor activity | ||
| extracellularly ATP-gated monoatomic cation channel activity | ||
| extracellularly ATP-gated monoatomic cation channel activity | ||
| extracellularly ATP-gated monoatomic cation channel activity | ||
| ATP binding |
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0110567 | autosomal dominant nonsyndromic deafness 41 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026